Home  |  Speakers  |  Agenda  |  Venue  |  Posters  |  Sponsors  |  Media  |  Register


Following the success of their 2015 meeting Global Engage is pleased to announce the 2nd Annual Biologics & Biosimilars Congress 2016 which will be held on February 1-2 in Berlin, Germany at the Maratim proArteHotel.  The meeting which attracted over 160 attendees last year will be co-located with our Biosimilars Congress which is being introduced this year after much demand. The conferences are part of our successful Drug Discovery series which includes events on synthetic biology, precision medicine, digital pathology, digital PCR and the human microbiome. 

The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years.  With growing commercial potential, good economic returns and lower attrition rates when compared to small molecule drugs as well as entry barriers on the manufacturing side reducing all the time, more and more companies are entering the expanding field.  The smaller, but lucrative, Biosimilars market is anticipated to grow well over $55 Billion post 2020 with growth due to numerous factors including current positive pipeline development, companies looking to take advantage of the highly lucrative third wave of biosimilar opportunity and government efforts worldwide to reduce healthcare costs.

Attracting industry, regulatory & academic experts working in all areas of protein, antibody & biosimilar research this two day interactive meeting will provide you the opportunity to take home cutting edge strategies, case study examples, regulatory guidelines, CMC considerations, to allow you to further your research, keep abreast of your competitors and stay on top of the latest technology/solution advancements and developments in the area in both Europe, US and worldwide.

This will be achieved through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, networking breaks allowing interaction with your peers, poster presentation sessions, expert led case study presentations and incisive Q&A panel discussions from a 70 strong speaker faculty examining topics on six separate tracks covering:

Biologics Congress:
Day 1 Stream 1 -
Antibody Based Therapeutics
Day 1 Stream 2 -
Protein Expression, Purification, & Characterization
Day 2 Stream 1 -
i    Antibody-Drug Conjugates

ii   Antibodies for Cancer Immunotherapy
Day 2 Stream 2 -
Protein Biotherapeutics

Biosimilars Congress:

Day 1 -             
Development Strategy, Market Access and Commercialization
Day 2 -
Overcoming Regulation & CMC Hurdles for Biosimilar Development

For a more detailed synopsis or to download the up to date agenda; please visit the agenda page.

Advisory Panel

                        ArvinteTudor Arvinte
Therapeomic Inc &
Unversity of Geneva

Stefan DubelStefan Dübel
Technische Universität Braunschweig

Peter NeubauerPeter Neubauer
Technische Universität Berlin
(TU Berlin)

Nicolas SabarthNicolas Sabath

Jacques DumasJacques Dumas

Rene HoetRene Hoet

Karl GriswoldKarl Griswold
Dartmouth - Stealth Biologics

Jinming GuJingming Gu

Nico MertensNico Mertens
Biotecnol SA

Annette SieversAnnette Sievers

Arne SkerraArne Skerra
TU Munchen

Ali TehraniAli Tehrani
Zymeworks Inc.

Mark ThrosbyMark Throsby

Thierry WurchThierry Wurch

[Back to Top]

To receive the first updates and get special offers before anyone else, please complete the form below.

Platinum Sponsor

Gold Sponsors

Silver Sponsor

Content Sponsors and Exhibitors

See all

Copyright:  Global Engage Ltd.   Registered in England.  No: 6950636